(Q40083810)

English

Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack

scientific article published on 5 June 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

author name string

Douglas C Wu

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Ashleigh Susan Boyd

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Kathryn J Wood

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

publication date

5 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1939-1950

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection.

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.2008-0078

21 January 2018

Complement-dependent control of teratoma formation by embryonic stem cells.

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.2008-0078

21 January 2018

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CELL.2007.11.019

Reprogramming of human somatic cells to pluripotency with defined factors

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE06534

Embryonic stem cell lines derived from human blastocysts

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.282.5391.1145

Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1073/PNAS.78.12.7634

Induced pluripotent stem cell lines derived from human somatic cells

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1151526

Identifiers

10.1634/STEMCELLS.2008-0078

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

release_4hpufcfspbeexgewatwicxliee

1 reference

https://api.fatcat.wiki/v0/release/4hpufcfspbeexgewatwicxliee

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40083810&oldid=1884643020"